Inspire Medical Systems is navigating a sharp growth deceleration, with revenue declining 7.6% year-over-year in 2026Q2, a stark contrast to the 28-32% growth seen in 2024. While gross margins remain resilient at 85.5%, heavy SG&A spending (73.4% of revenue) c...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 3, 2026 | $0.14+159.3% vs -$0.24 | $201M+3.0% vs $195M |
Q2 2026 May 4, 2026 | $0.10+136.3% vs -$0.28 | $205M+2.3% vs $200M |
Q1 2026 Feb 11, 2026 | $1.65+139.1% vs $0.69 | $269M+1.3% vs $266M |
Q4 2025 Nov 3, 2025 | $0.38+353.3% vs -$0.15 | $225M-14.4% vs $262M |
On September 18, 2026, Inspire Medical Systems Inc (INSP) shares rose 5.5% to a current price of $76.78. This price remains significantly below its 52-week high
Hsbc Holdings PLC trimmed its position in shares of Inspire Medical Systems, Inc. (NYSE: INSP) by 68.4% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,241 shares of the company's stock after selling 13,489 shares during
Medical Systems, American Well and Butterfly Network have been highlighted in this Industry Outlook article.
INSP, AMWL and BFLY are positioned to gain from digital health and AI demand despite cybersecurity risks.
Benchmark INSP against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Inspire Medical Systems, Inc. (INSP)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $69.06 | $1.99B | 14.12 | 13.6% | 15.95% | 19.77% | — | |
| $16.25 | $1.88B | -13.32 | 8.28% | -21.25% | -44% | — | |
| $16.38 | $1.12B | -5.39 | 7.93% | -6.08% | -45.97% | — | |
| $111.75 | $3.67B | -80.40 | 26.24% | -1.69% | -8.97% | — | |
| $89.30 | $114.65B | 23.94 | 8.43% | 13.93% | 10.51% | — | |
| $103.53 | $180.32B | 27.83 | 5.67% | 13.91% | 12.09% | — |
Inspire Medical Systems, Inc. (INSP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Inspire Medical Systems, Inc. (INSP) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 3, 2026·SEC
Jul 24, 2026·SEC
Jul 22, 2026·SEC
Get notified when INSP posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Inspire Medical Systems, Inc. (INSP) stock FAQ — growth, dividends, profitability & financials explained
Inspire Medical Systems, Inc. (INSP) reported $898.7M in revenue for fiscal year 2025. This represents a 5371% increase from $16.4M in 2016.
Inspire Medical Systems, Inc. (INSP) grew revenue by 13.6% over the past year. This is steady growth.
Yes, Inspire Medical Systems, Inc. (INSP) is profitable, generating $135.0M in net income for fiscal year 2025 (15.9% net margin).
Inspire Medical Systems, Inc. (INSP) has a return on equity (ROE) of 19.8%. This is reasonable for most industries.
Inspire Medical Systems, Inc. (INSP) generated $117.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
